NARCAN
Total Payments
$164,094
Transactions
3
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $164,094 | 3 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $164,094 | 3 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| EBS-NAR-001 | Emergent BioSolutions Inc. | $164,094 | 0 |
Top Doctors Receiving Payments for NARCAN
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Miami, FL | $164,094 | 3 |
Ad
Manufacturing Companies
- Emergent BioSolutions Inc. $164,094
Product Information
- Type Drug
- Total Payments $164,094
- Total Doctors 0
- Transactions 3
About NARCAN
NARCAN is a drug associated with $164,094 in payments to 0 healthcare providers, recorded across 3 transactions in the CMS Open Payments database. The primary manufacturer is Emergent BioSolutions Inc..
Payment data is available from 2023 to 2023. In 2023, $164,094 was paid across 3 transactions to 0 doctors.
The most common payment nature for NARCAN is "Unspecified" ($164,094, 100.0% of total).
NARCAN is associated with 1 research study, including "EBS-NAR-001" ($164,094).